塔法米迪斯的安全评估:来自FAERS数据库的现实世界不良事件分析
Min Chen1, Yaping Huang2, Chengjie Ke3,4
1Department of Orthopedics, Fujian Medical University Union Hospital, Fuzhou, China.
Expert opinion on drug safety
|December 5, 2024
概括
塔法米迪斯是治疗粉样纤维素的第一个药物,它显示出独特的不良事件,如脏和耳部疾病,这些不在其标签上. 这种对FDA数据的分析有助于优化其安全的临床使用.
科学领域:
- 药物监督 药物监督 药物监督
- 药物安全分析 药物安全分析
- 临床药理学 临床药理学
背景情况:
- 塔法米迪斯是第一个FDA批准的药物,用于治疗横氨基粉症.
- 与tafamidis相关的不良事件 (AE) 需要持续监测和分析.
- 该研究重点关注2019年第二季度至2023年第四季度期间报告的AE.
研究的目的:
- 分析与tafamidis相关的不良事件 (AEs).
- 从现实数据中识别出独特和共同的安全信号.
- 为优化tafamidis治疗和患者安全提供见解.
主要方法:
- 使用了FDA不良事件报告系统 (FAERS) 数据库.
- 从2019年第二季度到2023年第四季度收集和标准化的AE数据.
- 使用的信号量化技术:ROR,PRR,BCPNN和MGPS. 使用的信号量化技术:ROR,PRR,BCPNN和MGPS.
主要成果:
- 分析了8742份AE报告,其中tafamidis是主要的疑似药物.
- 在27个系统器官类别中确定了180个AE首选术语.
- 值得注意的发现包括独特的AE (脏,耳朵疾病) 和显著信号 (血培阳性,获得的血友病),以及常见的AE (死亡,跌倒,低音).
结论:
- 确定了与tafamidis治疗相关的新型不良事件.
- 突出显示常见和不常见的不良事件信号.
- 这些发现支持加强对tafamidis的临床监测和明智的治疗策略.
相关概念视频
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
01:12Hazard Ratio
90
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
90
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K